Related references
Note: Only part of the references are listed.Clopidogrel Pharmacogenetics State-of-the-Art Review and the TAILOR-PCI Study
Naveen L. Pereira et al.
CIRCULATION-CARDIOVASCULAR INTERVENTIONS (2019)
P2Y12 Inhibitor Switching in Response to Routine Notification of CYP2C19 Clopidogrel Metabolizer Status Following Acute Coronary Syndromes
Thomas J. Povsic et al.
JAMA CARDIOLOGY (2019)
A Genotype-Guided Strategy for Oral P2Y12 Inhibitors in Primary PCI
Daniel M. F. Claassens et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Use of Prasugrel and Ticagrelor in Stable Ischemic Heart Disease After Percutaneous Coronary Intervention, 2009-2016
Elias J. Dayoub et al.
CIRCULATION-CARDIOVASCULAR INTERVENTIONS (2019)
VA Primary Care and Mental Health Providers' Comfort with Genetic Testing: Survey Results from the PRIME Care Study
Leland E. Hull et al.
JOURNAL OF GENERAL INTERNAL MEDICINE (2019)
Multisite Investigation of Strategies for the Implementation of CYP2C19 Genotype-Guided Antiplatelet Therapy
Philip E. Empey et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2018)
Multisite Investigation of Outcomes With Implementation of CYP2C19 Genotype-Guided Antiplatelet Therapy After Percutaneous Coronary Intervention
Larisa H. Cavallari et al.
JACC-CARDIOVASCULAR INTERVENTIONS (2018)
Pharmacogenomic Approach to Selecting Antiplatelet Therapy in Patients With Acute Coronary Syndromes The PHARMCLO Trial
Francesca Maria Notarangelo et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)
Clinical Outcomes and Sustainability of Using CYP2C19 Genotype-Guided Antiplatelet Therapy After Percutaneous Coronary Intervention
Craig R. Lee et al.
CIRCULATION-GENOMIC AND PRECISION MEDICINE (2018)
Pharmacogenomics-Based Point-of-Care Clinical Decision Support Significantly Alters Drug Prescribing
P. H. O'Donnell et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2017)
The IGNITE Pharmacogenetics Working Group: An Opportunity for Building Evidence with Pharmacogenetic Implementation in a Real-World Setting
L. H. Cavallari et al.
CTS-CLINICAL AND TRANSLATIONAL SCIENCE (2017)
Physician Response to Implementation of Genotype-Tailored Antiplatelet Therapy
J. F. Peterson et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2016)
Contemporary Use of Ticagrelor in Interventional Practice (from Blue Cross Blue Shield of Michigan Cardiovascular Consortium)
Amrita M. Karve et al.
AMERICAN JOURNAL OF CARDIOLOGY (2015)
The Hawaii clopidogrel lawsuit: the possible effect on clinical laboratory testing
Alan H. B. Wu et al.
PERSONALIZED MEDICINE (2015)
Implementation and evaluation of a CYP2C19 genotype-guided antiplatelet therapy algorithm in high-risk coronary artery disease patients
John Andrew Lee et al.
PHARMACOGENOMICS (2015)
In-hospital switching between adenosine diphosphate receptor inhibitors in patients with acute myocardial infarction treated with percutaneous coronary intervention: Insights into contemporary practice from the TRANSLATE-ACS study
Akshay Bagai et al.
EUROPEAN HEART JOURNAL-ACUTE CARDIOVASCULAR CARE (2015)
MULTInational non-interventional study of patients with ST-segment elevation myocardial infarction treated with PRimary Angioplasty and Concomitant use of upstream antiplatelet therapy with prasugrel or clopidogrel - the European MULTIPRAC Registry
Peter Clemmensen et al.
EUROPEAN HEART JOURNAL-ACUTE CARDIOVASCULAR CARE (2015)
In-hospital switching of oral P2Y12 inhibitor treatment in patients with acute coronary syndrome undergoing percutaneous coronary intervention: Prevalence, predictors and short-term outcome
Dimitrios Alexopoulos et al.
AMERICAN HEART JOURNAL (2014)
In-Hospital Switching Between Clopidogrel and Prasugrel Among Patients With Acute Myocardial Infarction Treated With Percutaneous Coronary Intervention Insights Into Contemporary Practice From the National Cardiovascular Data Registry
Akshay Bagai et al.
CIRCULATION-CARDIOVASCULAR INTERVENTIONS (2014)
Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C19 Genotype and Clopidogrel Therapy: 2013 Update
S. A. Scott et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2013)
Pharmacogenetic testing: current evidence of clinical utility
Jivan Moaddeb et al.
THERAPEUTIC ADVANCES IN DRUG SAFETY (2013)
Primary care physicians' knowledge of and experience with pharmacogenetic testing
S. B. Haga et al.
CLINICAL GENETICS (2012)
Adoption of Pharmacogenomic Testing by US Physicians: Results of a Nationwide Survey
E. J. Stanek et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2012)
Dosing Clopidogrel Based on CYP2C19 Genotype and the Effect on Platelet Reactivity in Patients With Stable Cardiovascular Disease
Jessica L. Mega et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions
Glenn N. Levine et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2011)
Identification of the Human Cytochrome P450 Enzymes Involved in the Two Oxidative Steps in the Bioactivation of Clopidogrel to Its Pharmacologically Active Metabolite
Miho Kazui et al.
DRUG METABOLISM AND DISPOSITION (2010)
Reduced-Function CYP2C19 Genotype and Risk of Adverse Clinical Outcomes Among Patients Treated With Clopidogrel Predominantly for PCI A Meta-analysis
Jessica L. Mega et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2010)
Association of Cytochrome P450 2C19 Genotype With the Antiplatelet Effect and Clinical Efficacy of Clopidogrel Therapy
Alan R. Shuldiner et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
Lars Wallentin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Common polymorphisms of CYP2C19 and CYP2C9 affect the pharmacokinetic and pharmacodynamic response to clopidogrel but not prasugrel
J. T. Brandt et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2007)
Prasugrel versus clopidogrel in patients with acute coronary syndromes
Stephen D. Wiviott et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Platelet function monitoring in patients with coronary artery disease
Paul A. Gurbel et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2007)
Share Paper
